Publications by authors named "Kersten M"

CD19-directed chimeric antigen receptor (CAR) T-cell therapy, originally developed for haematological malignancies, has recently emerged as a promising therapy for patients with autoimmune diseases. By selectively depleting CD19-positive B-cells, this therapy brings a new approach in resetting immune dysregulation and potentially providing long-term remission for patients with a refractory disease. Recent reports have highlighted its effectiveness in conditions such as SLE, systemic sclerosis and myositis.

View Article and Find Full Text PDF

Differentiation of antigen-activated B cells into pro-proliferative germinal center (GC) B cells depends on the activity of the transcription factors MYC and BCL6, and the epigenetic writers DOT1L and EZH2. GCB-like Diffuse Large B Cell Lymphomas (GCB-DLBCLs) arise from GCB cells and closely resemble their cell of origin. Given the dependency of GCB cells on DOT1L and EZH2, we investigated the role of these epigenetic regulators in GCB-DLBCLs and observed that GCB-DLBCLs synergistically depend on the combined activity of DOT1L and EZH2.

View Article and Find Full Text PDF

Sulfide mineral oxidation has been recognized as the key driver of arsenic (As) and antimony (Sb) mobility in mining-impacted groundwater. However, the role of carbonate and silicate weathering and secondary mineral precipitation in this process remain unknown. A comprehensive geochemical study of groundwater was conducted in an Sb-mining area, Hunan, China, with samples collected from aquifers of the Xikuangshan Formation (Dx), the Shetianqiao Formation (Ds ), and the Lower Carboniferous Formation (Cy).

View Article and Find Full Text PDF

Introduction: Enteropathy-associated T-cell lymphoma (EATL) is a peripheral T-cell lymphoma (PTCL) with a poor prognosis. Cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) with or without etoposide consolidated by autologous stem cell transplantation (ASCT) are recommended for fit PTCL patients. The role of etoposide and ASCT in EATL is unclear.

View Article and Find Full Text PDF
Article Synopsis
  • * The Cardiac Health in Breast Cancer study aims to evaluate how a structured exercise program impacts cardiac health in 48 females undergoing cardiotoxic cancer therapies.
  • * Participants will be divided into an intervention group receiving high-intensity training and a control group following general activity guidelines, with a focus on measuring changes in cardiac function and overall well-being over 12 months.
View Article and Find Full Text PDF

Background: Understanding health-related quality of life (HRQoL) dynamics is essential for assessing and improving treatment experiences; however, clinical and observational studies struggle to capture their full complexity. We use simulation modeling and the case of Chimeric Antigen Receptor T-cell therapy-a type of cancer immunotherapy that can prolong survival, but carries life-threatening risks-to study HRQoL dynamics.

Methods: We developed an exploratory system dynamics model with mathematical equations and parameter values informed by literature and expert insights.

View Article and Find Full Text PDF

Given the rarity of primary central nervous system lymphoma (PCNSL), evaluations of different high-dose methotrexate-(HD-MTX)-based treatment regimens is sparse. This retrospective, multicenter study evaluates clinical characteristics and outcomes (progression-free, overall and disease-specific survival) after five HD-MTX-based polychemotherapeutic regimens and two consolidation therapies. 346 patients with histologically confirmed PCNSL, treated with ≥ 1 cycle HD-MTX-based strategies (≥3g/m/cycle) were included.

View Article and Find Full Text PDF

First-line treatment for advanced-stage diffuse large B-cell lymphoma (DLBCL) typically involves 6x R-CHOP21 or 6x R-CHOP21 with two additional rituximab administrations (6x R-CHOP21 + 2 R). In contemporary practice, this treatment choice might be guided by interim PET scan results. This nationwide, population-based study investigates the comparative effectiveness of these treatment regimens in an era where interim PET-guided treatment decisions were not standard practice.

View Article and Find Full Text PDF
Article Synopsis
  • The EHA-ESMO Clinical Practice Guideline offers important recommendations for the diagnosis, staging, treatment, and follow-up of HIV-associated lymphomas.
  • It includes insights from a diverse team of experts in oncology from various European institutions.
  • The recommendations are grounded in scientific research and the collective expertise of the authors.
View Article and Find Full Text PDF

Aims: There is a lack of therapies able to prevent anthracycline cardiotoxicity (AC). Remote ischaemic conditioning (RIC) has shown beneficial effects in preclinical models of AC.

Methods: REmote iSchemic condItioning in Lymphoma PatIents REceiving ANthraCyclinEs (RESILIENCE) is a multinational, prospective, phase II, double-blind, sham-controlled, randomized clinical trial that evaluates the efficacy and safety of RIC in lymphoma patients receiving anthracyclines.

View Article and Find Full Text PDF
Article Synopsis
  • - Axicabtagene ciloleucel (axi-cel) is an approved CAR T-cell therapy for relapsed/refractory large B-cell lymphoma, but it often causes side effects like cytokine release syndrome (CRS) and neurological events (NEs).
  • - To investigate ways to reduce these toxicities, the ZUMA-1 trial included a safety cohort (Cohort 3) that used the drug tocilizumab and anticonvulsant levetiracetam as preventive measures during treatment.
  • - In a 24-month follow-up of 42 patients in Cohort 3, 92% experienced any-grade CRS and 87% had NEs, while the overall response rate was 63
View Article and Find Full Text PDF
Article Synopsis
  • The HOVON 104 study involved 50 patients receiving bortezomib-dexamethasone therapy followed by autologous stem cell transplantation (ASCT), with 35 patients undergoing the transplantation.
  • The study reported a 5-year overall survival rate of 73% and progression-free survival of 52% for all patients, while those who received ASCT had even better outcomes, with 5-year overall survival at 91% and progression-free survival at 68%.
  • Notably, the study indicated a 60% complete response in organ function after ASCT, with cardiac responses stabilizing after 2 years and renal responses gradually improving, achieving completeness in 61% of affected patients by 5 years.
View Article and Find Full Text PDF

A lateral expansion of molecular spoked wheels (MSWs) based on an all-phenylene backbone is described. The MSWs contain a central hub, six spokes, and a rim that is formed by a sixfold Yamamoto coupling of the respective non-cyclized dodecabromo precursor yielding MSWs with up to 30 phenylene rings in the perimeter. Attempts to prepare compounds of such size without flexible side groups at the spokes were unsuccessful, most probably due to an aggregation and accompanying oligomerization of the precursors during the cyclization.

View Article and Find Full Text PDF
Article Synopsis
  • - The study assessed COVID-19 mortality rates among patients receiving Chimeric Antigen Receptor (CAR) T-cell therapy for blood cancers, comparing outcomes across three years (2020, 2021, 2022) during the Omicron period.
  • - There was a significant decline in COVID-19-related mortality: from 43.6% in 2020 to 7.5% in 2022, indicating improvement over time, with year of infection identified as a key predictor of survival.
  • - Although mortality decreased, CAR T-cell recipients still face a higher risk of complications compared to the general population, highlighting the need for ongoing monitoring and preventive measures during their treatment.
View Article and Find Full Text PDF

Dissolved organic matter (DOM) plays a predominant role in groundwater arsenic (As) mobility. However, the temporal-spatial variations in DOM fluorescent characteristics and their effects on As mobility induced by groundwater irrigation remain unclear. To address these issues, groundwater from multilevel and irrigation wells in Zones I and II (with low- and high-As groundwater irrigation, respectively) from the Hetao Basin, China, were monitored in both non-irrigation (NIG) and irrigation (IG) seasons.

View Article and Find Full Text PDF

Axicabtagene ciloleucel (axi-cel), an autologous anti-CD19 chimeric antigen receptor T-cell therapy, was approved for relapsed/refractory (R/R) large B-cell lymphoma (LBCL) based on the results from pivotal Cohorts 1+2 of ZUMA-1 (NCT02348216). ZUMA-1 was expanded to investigate safety management strategies aimed at reducing the incidence and severity of cytokine release syndrome (CRS) and neurologic events (NEs). Prospective safety expansion Cohort 5 evaluated the impact of debulking therapy, including rituximab-containing immunochemotherapy regimens and radiotherapy, in axi-cel-treated patients; the CRS and NE management strategy paralleled those in Cohorts 1+2.

View Article and Find Full Text PDF

The production of cultured red blood cells (cRBC) for transfusion purposes requires large scale cultures and downstream processes to purify enucleated cRBC. The membrane composition, and cholesterol content in particular, are important during proliferation of (pro)erythroblasts and for cRBC quality. Therefore, we tested the requirement for cholesterol in the culture medium during expansion and differentiation of erythroid cultures with respect to proliferation, enucleation and purification by filtration.

View Article and Find Full Text PDF

Azobenzenes (ABs) are versatile compounds featured in numerous applications for energy storage systems, such as solar thermal storages or phase change materials. Additionally, the reversible one-electron reduction of these diazenes to the nitrogen-based radical anion has been used in battery applications. Although the oxidation of ABs is normally irreversible, 4,4'-diamino substitution allows a reversible 2e oxidation, which is attributed to the formation of a stable bis-quinoidal structure.

View Article and Find Full Text PDF

Background: Employees in social work exhibit high rates of sick leave due to mental health issues. Additionally, work-related demands in youth welfare have increased in recent years. Particularly in light of the escalating shortage of skilled professionals in this field, this trend becomes especially critical.

View Article and Find Full Text PDF

Optimal treatment in patients with refractory or relapsed peripheral T-cell lymphomas (R/R T-NHLs) is unknown. In this population-based study, outcomes in R/R peripheral T-cell lymphoma not otherwise specified (PTCL NOS), angioimmunoblastic T-cell lymphoma (AITL), and anaplastic lymphoma kinase-positive (ALK+) and ALK-negative (ALK-) anaplastic large cell lymphoma (ALCL) were evaluated. Patients with PTCL NOS, AITL, ALK+ ALCL, and ALK- ALCL (≥18 years) diagnosed in 2014 to 2019 were identified using the Netherlands Cancer Registry.

View Article and Find Full Text PDF
Article Synopsis
  • Metabolic tumor volume (MTV), measured via PET scans, is a potential indicator of prognosis in large B-cell lymphoma (LBCL) patients, particularly in assessing how tumor burden affects treatment outcomes.
  • The ZUMA-7 study compared outcomes between patients receiving axicabtagene ciloleucel (axi-cel) and standard care, revealing that those with lower MTV (median or less) generally had better event-free survival (EFS) and progression-free survival (PFS) across both treatments.
  • Patients with high MTV showed poorer survival rates and more severe side effects, emphasizing the need for assessing MTV as a predictor of treatment response in future LBCL therapies.
View Article and Find Full Text PDF

Several single-arm studies have explored the inclusion of brentuximab vedotin (BV) in salvage chemotherapy followed by autologous stem cell transplantation (ASCT) for relapsed/refractory (R/R) classical Hodgkin lymphoma (cHL). However, no head-to-head comparisons with standard salvage chemotherapy have been performed. This study presents a propensity score-matched analysis encompassing individual patient data from 10 clinical trials to evaluate the impact of BV in transplant-eligible patients with R/R cHL.

View Article and Find Full Text PDF
Article Synopsis
  • BTK inhibitors have improved outcomes for mantle cell lymphoma (MCL) patients, but the disease remains incurable due to resistance issues.
  • Research indicates that HCK, a Src-family tyrosine kinase, is linked to poor prognosis in MCL and its inhibition can limit cell growth and adhesion.
  • The dual inhibitor KIN-8194 effectively targets both BTK and HCK, showing strong anti-growth effects on MCL cells regardless of their resistance to existing BTK inhibitors, suggesting its potential as a new treatment option.
View Article and Find Full Text PDF